Mirae Asset Global Etfs Holdings Ltd. Arcellx, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Arcellx, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 22,755 shares of ACLX stock, worth $2.35 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,755Holding current value
$2.35 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACLX
# of Institutions
179Shares Held
45.9MCall Options Held
53.6KPut Options Held
53.7K-
Perceptive Advisors LLC New York, NY3.89MShares$401 Million6.21% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.85MShares$397 Million8.59% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$386 Million19.51% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$362 Million0.0% of portfolio
-
Sr One Capital Management, LP2.35MShares$242 Million56.87% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $4.52B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...